Theranos founder fooled investors with the promise to revolutionize healthcare – it offers three big lessons for companies
Theranos founder fooled investors with the promise to revolutionise healthcare – it offers three big lessons for companies
Article

Theranos founder fooled investors with the promise to revolutionize healthcare – it offers three big lessons for companies

Elizabeth Holmes has been charged with 'massive fraud'. She maintains her innocence but what lessons can boards take away from the whole affair?
5 min.
June 2018
PRINTABLE PDF – Less than 1MB

Less than three months after being charged by the US Securities and Exchange Commission(SEC) with “massive fraud” and barred from being the CEO of a public company for ten years, entrepreneur Elizabeth Holmes is reportedly on the hunt for investors for a new company.

She is still allowed to be the CEO of a privately held company – but would-be investors should heed the lessons from Holmes’ last venture, Theranos.

In 2003, 19-year-old Holmes dropped out of Stanford and founded the health tech firm, Theranos. It worked in “stealth mode” for a decade while developing new technology to perform many standard medical tests using only a single drop of blood. After unveiling the company’s device and its plans to revolutionize the healthcare industry, Holmes was heavily profiled in the media and embraced the role of guru.

Contact

Research Information & Knowledge Hub for additional information on IMD publications

Looking for something specific?
IMD's faculty and research teams publish articles, case studies, books and reports on a wide range of topics